HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
BMY
Bristol-Myers Squibb Company
Healthcare Drug Manufacturers - General · New York, USA · Reports in usd
Market Cap: $130.35B
Market Cap
$130.35B
Enterprise Val
$162.40B
P/E Ratio
14.04
P/B Ratio
5.84
Trailing PEG (1Y)
0.09
As Of
Aug 13, 2026

Overview & Key Metrics

Reporting period: Jun 30, 2026 · Q2 2026
Book Value$22.32B
Gross Margin71.28%
Profit Margin71.28%
Return on Equity46.75%
Return on Assets10.28%
Current Ratio1.53
Debt/Equity1.93
LT Debt/Equity1.89
Revenue Per Share6.35

Income Statement

Jun 30, 2026
Revenue$12.97B
Cost of Revenue$3.73B
Gross Profit$9.25B
R&D$2.96B
SG&A$1.83B
Operating Expenses$5.16B
Operating Income$4.09B
Interest Expense$0.00
Tax Expense$770.0M
Net Income$3.32B
EPS (Basic)$1.62
EPS (Diluted)$1.62
EBIT$4.09B
EBITDA$4.68B
Consolidated Income$3.32B
Non-Controlling Interests-$1.0M

Balance Sheet

Jun 30, 2026
Cash & Equivalents$8.72B
Accounts Receivable$10.55B
Inventory$2.74B
Current Assets$28.58B
LT Investments$397.0M
Property, Plant & Equipment$7.79B
Intangibles$39.13B
Non-Current Assets$59.06B
Total Assets$87.63B
Accounts Payable$4.16B
Current Debt$1.03B
Current Liabilities$18.66B
LT Debt$42.09B
Non-Current Liabilities$46.66B
Total Liabilities$65.32B
Total Debt$43.12B
Retained Earnings$20.32B
Shareholder Equity$22.32B
Shares Outstanding2,042,071,247

Cash Flow Statement

Jun 30, 2026
Operating Cash Flow$3.39B
Investing Cash Flow-$1.61B
Financing Cash Flow-$2.63B
CapEx-$305.0M
Free Cash Flow$3.09B
Depreciation & Amort.$594.0M
Stock-Based Comp$135.0M
Acquisitions / Disposals$118.0M
Investment Activity-$1.43B
Debt Issued/Repaid-$1.35B
Equity Issued/Repaid$7.0M
Dividends Paid-$1.29B
Net Change in Cash-$861.0M
Data cached · Meta cache · Daily cache · Statements cache · TTL 24h